Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06566482

Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA

Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia for Postoperative Sleep Promotion in Patients at High-risk of Obstructive Sleep Apnea: A Randomized Trial

Sponsor: Peking University First Hospital

Conditions Dexmedetomidine Esketamine Obstructive Sleep Apnea Postoperative Sleep Quality Surgery

Interventions Dexmedetomidine-esketamine combination Placebo

Updated 2 times since 2024 Last updated: Sep 23, 2024 Started: Sep 11, 2024 Primary completion: Sep 30, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Dexmedetomidine and Esketamine, this trial is actively recruiting participants. The trial is conducted by Peking University First Hospital and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Oct 2024 — Present [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University First Hospital

Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China